臨床試驗支援服務的全球市場規模、佔有率、成長分析（按階段、按適應症）－產業預測，2024-2031

2022年全球臨床試驗支援服務市場規模為208.6億美元，預測期間（2024-2031年）年複合成長率為7.50%，從2023年的224.2億美元成長到2031年的399.9億美元2019年。

臨床試驗支援服務、分析設計和臨床試驗都非常有益。它還包括管理套件、計算藥物劑量、保護臨床試驗地點以及保護和儲存研究藥物。臨床前基礎知識和研究由臨床試驗支援服務提供，包括臨床試驗現場支援、研究藥物的獲取和儲存、研究藥物的盲法、患者招募、協調以及返回藥物的協調。2021年，臨床試驗領域發生了重大變化。隨著COVID-19疫苗接種的發展，許多因疫情而推遲的臨床試驗已經恢復。臨床試驗是創造治療新藥所必需的，這方面還有許多未滿足的需求。這是因為開發中國家感染疾病、慢性病和熱帶疾病的發生率很高。虛擬臨床試驗的使用已成為大流行後該行業臨床試驗支援服務部門收益成長的主要驅動力。越來越多的臨床研究公司轉向虛擬技術來簡化臨床研究服務。

目錄

執行摘要

• 市場概況
• 命運之輪

調查方法

• 資訊採購
• 二級/一級資訊來源
• 市場規模估算
• 市場假設與限制

母市場分析

• 市場概況
• 市場規模
• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 課題

主要市場考察

• 技術分析
• 價格分析
• 供應鏈分析
• 價值鏈分析
• 市場生態系統
• 智慧財產權分析
• 貿易分析
• Start-Ups分析
• 原料分析
• 創新矩陣
• 研發線產品分析
• 宏觀經濟指標
• 主要投資分析
• 關鍵成功因素
• 競爭程度

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 課題
• 監管環境
• 波特的分析
• 對未來顛覆的特別見解

全球臨床試驗支援服務市場：依階段

• 市場概況
• Ⅰ
• Ⅱ
• Ⅲ
• Ⅳ

全球臨床試驗支援服務市場：按適應症分類

• 市場概況
• 自體免疫/發炎
• 腫瘤學
• 糖尿病
• 心血管

全球臨床試驗支援服務市場規模：依地區分類

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲（MEA）
  • 海灣合作理事會國家
  • 南非
  • 其他中東、非洲地區

競爭格局

• 前5名企業比較
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 關鍵成功策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• IQVIA Holdings Inc.
• PAREXEL International Corporation（a subsidiary of Pamplona Capital Management）
• Charles River Laboratories International Inc.
• PRA Health Sciences Inc.
• ICON Plc
• Syneos Health Inc.
• Pharmaceutical Product Development LLC（PPD）
• Wuxi AppTec Inc.
• Medpace Holdings Inc.
• SGS SA
• Covance Inc.（a subsidiary of LabCorp）
• Celerion Inc.
• Clinipace Worldwide
• Worldwide Clinical Trials Inc.
• Novotech Pty Ltd.
• MMS Holdings Inc.
• Premier Research Group Ltd.
• Medidata Solutions Inc.
• Anavex Life Sciences Corp.
• Cromsource Srl

Global Clinical Trials Support Services Market size was valued at USD 20.86 billion in 2022 and is poised to grow from USD 22.42 billion in 2023 to USD 39.99 billion by 2031, at a CAGR of 7.50% during the forecast period (2024-2031).

Clinical trial support services, assay design, and clinical testing are all highly beneficial. It also involves maintaining kits, calculating drug dosages, protecting clinical test sites, and securing and storing research drugs. Preclinical foundation and research are provided by clinical test support services, which also include assistance with clinical test sites, obtaining and storing study medicines, blinding study drugs, recruiting patients, coordinating, and reconciling returned pharmaceuticals. The clinical trial sector saw substantial transformation in 2021. As COVID-19 vaccinations were developed, many clinical trials that had been delayed due to the pandemic were reopened. Clinical trials are required in order to create novel medications for therapy, as there are many unfulfilled requests in this regard. This is because developing countries have higher rates of infectious, chronic, and tropical diseases. The utilization of virtual clinical trials has been a major factor in the post-pandemic revenue expansion of the industry's clinical trials support services sector. A growing number of clinical research companies are focusing on the use of virtual technologies to streamline their clinical research services.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clinical Trials Support Services Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Clinical Trials Support Services Market Segmental Analysis

The clinical trials support market is segmented into phases, indication and sponsor. The Clinical Trials Support Services Market is divided into four phases: phases I, II, III, and IV. The Clinical Trials Support Services Market is divided into categories for autoimmune/inflammation, oncology, diabetes, cardiovascular, and others based on indication. The Clinical Trials Support Services Market is divided into pharmaceutical and biopharmaceutical businesses, medical device companies, and other companies based on the sponsor. Based on Region Clinical Trials Support Services Market is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Drivers of the Global Clinical Trials Support Services Market

The primary drivers of the market's growth include the increased prevalence of infectious and chronic diseases, pharmaceutical companies' large R&D expenditures, the rise of contract research organizations, and the need for clinical trials in developing nations.

Restraints in the Global Clinical Trials Support Services Market

The absence of advanced medical technology and infrastructure is impeding the market's growth. Rigid patient recruiting policies and insufficient trial management frameworks are further major barriers impeding the overall growth of the global clinical trial support services market. Nevertheless, the globalization of clinical trials and the evolution of technology brought about by continuous research and development present a profitable opportunity.

Market Trends of the Global Clinical Trials Support Services Market

The growing need for trials in developing countries, increased investment in research and development, and an increase in the quantity of contract research organizations are all indicators of the global market's rapid expansion (CROs). The pharmaceutical corporations have been increasing their research and development (R&D) investment annually, primarily due to the expiration of patents.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Clinical Trials Support Services Market by Phase

• Market Overview
• phases I
• II
• III
• and IV

Global Clinical Trials Support Services Market by Indication

• Market Overview
• Autoimmune/Inflammation
• Oncology
• Diabetes
• Cardiovascular

Global Clinical Trials Support Services Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• IQVIA Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PAREXEL International Corporation (a subsidiary of Pamplona Capital Management)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PRA Health Sciences Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON Plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmaceutical Product Development LLC (PPD)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wuxi AppTec Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medpace Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covance Inc. (a subsidiary of LabCorp)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celerion Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinipace Worldwide
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Worldwide Clinical Trials Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novotech Pty Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MMS Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Premier Research Group Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medidata Solutions Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anavex Life Sciences Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cromsource Srl
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments